Glucans as New Anticancer Agents
Language English Country Greece Media print
Document type Journal Article, Review
PubMed
31262858
DOI
10.21873/anticanres.13480
PII: 39/7/3373
Knihovny.cz E-resources
- Keywords
- Glucan, cancer, fiber, immunity, nutrition, review,
- MeSH
- Glucans pharmacology therapeutic use MeSH
- Humans MeSH
- Neoplasms drug therapy MeSH
- Antineoplastic Agents pharmacology therapeutic use MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Names of Substances
- Glucans MeSH
- Antineoplastic Agents MeSH
For decades, glucans have been studied for their biological and immunological activities. The scientific community has mainly focused on immune reactions, but other areas, such as cholesterol levels and diabetic retinopathy, have shown the positive effects of glucan supplementation. However, the majority of studies focused on possible cancer suppression, where glucans showed clear and significant effects on numerous types of cancers, leading not only to clinical trials, but to approval as an official drug. The aim of this review is to describe the current knowledge of this field.
Department of Immunology Institute of Microbiology Prague Czech Republic
Department of Pathology and Laboratory Medicine University of Louisville Louisville KY U S A
Institute of Public Health in Usti nad Labem Ústí nad Labem Czech Republic
References provided by Crossref.org
Trained Immunity as an Adaptive Branch of Innate Immunity